PTC Therapeutics IncNASDAQ
Historical Stock Data
|52 Week High|
|52 Week Low|
Biogen and Ionis Crash on PTC Therapeutics' Promising Data
Yesterday, PTC Therapeutics (PTCT) registered a stock price rise of ~24.6% on the positive data the company presented along with partner Roche (RHHBY) for their SMA (spinal muscular atrophy) drug risdiplam.
Vertex Presented Successful Results for Cystic Fibrosis Treatment
Vertex Pharmaceuticals’ peers that are actively conducting research and development for CF drugs include Pfizer (PFE), PTC Therapeutics (PTCT), Proteostasis Therapeutics (PTI), Novartis, and Roche.